Cargando…
Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
Zuclopenthixol is available in two parenteral formulation,i.e., in the form of acetate and decanoate. It has high affinity for dopamine D1 and D2 receptors. There is limited literature of association of neuroleptic malignant syndrome with the use of zuclopenthixol monotherapy. These case reports hav...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989464/ https://www.ncbi.nlm.nih.gov/pubmed/33776291 http://dx.doi.org/10.4103/ipj.ipj_54_19 |
Search Result 1